EDMONTON, Alberta, Nov. 15 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) is pleased to announce that it has received regulatory permission to sell its VScan HIV test kit in Saudi Arabia. Testing completed by regulatory agencies shows that once again the VScan test kit exceeded 99% accuracy in terms of sensitivity and specificity. The Company is currently negotiating several large orders with distributors in the Middle East. Market studies and information obtained from regulatory agencies shows that the market in the Middle East will exceed 1,000,000 test kits per year. In regard to Europe, the VScan HIV test kit is currently approved by regulatory agencies in Russia, Ukraine, Balkans and India. The Company through its distributor has applied for approval in the European Union (CE). Once approval in the European Union is obtained, the Company will have extensive coverage all over Europe, Asia and the Middle East. VScan test kits are currently being shipped into 17 countries in the above noted areas. With the anticipated CE approval that number will increase significantly. Worldwide, the Company is currently shipping into 29 countries. Within the next year, the Company expects to increase the number of countries it is shipping VScan test kits to greater than 60. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF." For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright